Mushroom-derived AHCC seems to stimulate the immune system.
AHCC is an extract derived from shiitake mushrooms. It appears to stimulate the immune system, resulting in potential benefits such as:
- Antiviral and antibacterial protection. AHCC improves the body’s defenses against viral and bacterial infections.
- Enhanced immune function. AHCC promotes immune cell activity.
Short for Active Hexose Correlated Compound, AHCC is an extract isolated from the edible shiitake mushroom (Lentinula edodes). More specifically, AHCC is extracted from the the mushroom’s root-like fungal growths known as mycelia. While AHCC combines multiple compounds including amino acids and minerals, its main ingredient is a type of carbohydrate called oligosaccharide.
AHCC was developed in Japan in the 1980s, and has since then spread to China and the West. Today, it is a popular dietary supplement for allergies, infections, diabetes, inflammatory conditions including IBD, stress, and other ailments. The overall effect of AHCC is best summed up as stimulation of the immune system.
How AHCC Might Help With Immunity<
AHCC seems to work by stimulating the immune system. In particular, AHCC has been shown to influence toll-like receptors (TLRs) found in immune tissue, resulting in effects such as higher levels of IL-10 (an anti-inflammatory cytokine), activation of lymphocytes, increased natural killer cell activity, and more.2 3<
AHCC Uses & Potential Immunity
AHCC is a popular all-around immune system booster. Particular immunity benefits ascribed to AHCC include resistance to viral and bacterial infections and anti-inflammatory activity.
There is some scientific evidence to support these effects; as one review summarizes: “Available data suggest that AHCC supplementation clearly affects immune outcomes and immune cell populations.”4 However, researchers also stress the need for more human trials.
AHCC has been extensively studied in animals and rodents in particular. Specific findings suggest that it might:
- Ward off bacterial infections. AHCC has been shown to reduce lung inflammation caused by the difficult-to-treat Mycobacterium avium-intracellulare bacterial infection, and enhance the immune response to intramuscular infection in rodents.5 6
- Ward off viral infections. AHCC supplementation appears to reduce flu severity and improve survival in young mice.7 In addition, it also improves immune defenses against the West Nile virus in mice. 8
Clinical trials of AHCC are just beginning, but support the positive findings of animal and cell culture studies.
This randomized, double-blind placebo-controlled study explored the immunostimulatory properties of AHCC. Twenty-nine people were given placebo or AHCC (3 g) daily for 2 weeks after flu vaccination. Compared to placebo, the AHCC group had a significant increase in percentage of several types of immune cells including T cells, CD8+ T cells, and NK cells after 2 weeks.
- The researchers concluded that “…short-term AHCC supplementation may be a good therapeutic intervention to sustain, or increase, the immune response to influenza vaccination…”9
This double-blind, placebo-controlled, randomized study examined the effects of AHCC on the immune system. Twenty-one adults were given placebo or AHCC (3 g) daily for 4 weeks. Compared to placebo and pre-supplementation, the AHCC group saw an increase in dendritic cells (DCs) that function as messengers in the immune system, and also had an improved mixed-leukocyte reaction (MLR).
- The researchers concluded that “AHCC intake resulted in the increased number of DCs and function of DC1s, which have a role in specific immunity.“10
This randomized study tested the immunity effects of AHCC. Thirty adults were vaccinated for influenza, and split into a control and AHCC groups (3 g daily). Compared to controls, the AHCC group had an improved immune response to vaccination, as indicated by more NKT and CD8 T cells, and an improved antibody response.
- The researchers concluded that “…our study showed that AHCC supplementation improved some lymphocyte percentages and influenza B antibody titers over the control.”11
Dosage for Immunity>
Supplements in Review Says>
Although more human research is needed, current evidence shows that AHCC is an effective immunity booster. The findings of cell culture, animal, and initial human studies demonstrate that AHCC has multiple immunity benefits including protection against viral & bacterial infections and overall enhanced immune function.
Existing research agrees on a 3 g dose. Most successful human studies of AHCC use a 3 g dose, making it the ideal choice.
- Aviles H et al. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol (1985). 2004 Oct;97(4):1437-44. ↩
- Mallet JF et al. Role of intestinal epithelial cells and involvement of TLRs in immune effects of AHCC. April 2014. The FASEB Journal vol. 28 no. 1 Supplement 638.4 ↩
- Olamigoke L et al. AHCC Activation and Selection of Human Lymphocytes via Genotypic and Phenotypic Changes to an Adherent Cell Type: A Possible Novel Mechanism of T Cell Activation. Evid Based Complement Alternat Med. 2015;2015:508746. ↩
- Ritz B. Active Hexose Correlated Compound (AHCC) and Immune Outcomes in Humans: A Review. Nat Med J. January 2011 Vol. 3 Issue 1. ↩
- Fujita M et al. Attenuation of Pulmonary Mycobacterium Avium Disease by Active Hexose Correlated Compound (AHCC) in Mice. J Nutr Disorders Ther 5:174. ↩
- Aviles H et al. Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection. Am J Surg. 2008 Apr;195(4):537-45. ↩
- Ritz BW et al. Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. J Nutr. 2006 Nov;136(11):2868-73. ↩
- Wang S et al. Oral Administration of Active Hexose Correlated Compound Enhances Host Resistance to West Nile Encephalitis in Mice. J Nutr. 2009 Mar; 139(3): 598–602. ↩
- Gardner EM et al. Active Hexose Correlated Compound (AHCC) improves immune cell populations after influenza vaccination of healthy subjects. April 2010. The FASEB Journalvol. 24 no. 1 Supplement lb327 ↩
- Terakawa N et al. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutr Cancer. 2008;60(5):643-51. ↩
- Roman BE et al. Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. Nutr Res. 2013 Jan;33(1):12-7. ↩